Construction of a novel diagnostic technology by using metabolomics in patients with urological cancers

Construction of a novel diagnostic technology by using metabolomics in patients with urological cancers - metabolomics in patients with urological cancers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028290

Enrollment

1000

Registered

2017-07-19

Start date

2017-07-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal cancer, bladder cancer, prostate cancer, urothelial cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent surgery with renal or urothelial, bladder, prostate cancer

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Evaluation of a novel marker for urologic cancers by using metabolomics	—

Countries

Japan

Contacts

Public ContactDaiji Watanabe

The University of Tokyo Department of Urology, Graduate School of Medicine

watanabed-uro@h.u-tokyo.ac.jp+81-3-5800-8753

Outcome results